Literature DB >> 28039521

ECHS1 deficiency-associated paroxysmal exercise-induced dyskinesias: case presentation and initial benefit of intervention.

Abhimanyu Mahajan1, Jules Constantinou2, Christos Sidiropoulos2,3.   

Abstract

Paroxysmal exercise-induced dyskinesias (PED) are paroxysmal dyskinesias which manifest as dystonic movements brought on by sustained exercise. ECHS1 deficiency-induced EID was recently described by Olgiati et al. Our patient is an 8-year-old boy, who presented with intermittent episodes of stiffness and contractions affecting the legs which were always brought on by vigorous exertion. They began with curling of the toes and flexion, followed by stiffening of gait. These episodes were asymmetric, uncomfortable and often began in the left leg, often spreading to the right leg. They generally lasted for about 30-40 min. The phenomenology was noted to be dystonic affecting mostly the left leg, with equinus at the ankle and hyperextension at the knee. MRI of the brain showed regions of increased T2 and FLAIR signal and of T1 low signal in the globus pallidus bilaterally with mild diffusion restriction. Using Ambry's ExomeNextTM, an integrated exome sequencing assay, the patient was found to be heterozygous for alterations in the ECHS1 gene: missense mutations in c.518C>T (p.A173V) and c.817A>G (p.K273E). After 3 months of treatment with a mitochondrial cocktail, the patient reported that his attacks were somewhat less frequent and less severe. We decided to continue the patient on the cocktail and prescribed clonazepam 0.5 mg 1 tab to be given, as needed, for acute dystonic episodes of severe degree. The missense mutation c.817A>G has never been associated with PED before. Further, we present the first case of ECH1-associated PED with initial symptomatic improvement with a mitochondrial cocktail.

Entities:  

Keywords:  Exercise-induced dystonia; Genetic dystonia; Movement disorders; Paroxysmal dystonia

Mesh:

Substances:

Year:  2016        PMID: 28039521     DOI: 10.1007/s00415-016-8381-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

Review 1.  Paroxysmal dyskinesias.

Authors:  Kailash P Bhatia
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

2.  Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome.

Authors:  Martine Tetreault; Somayyeh Fahiminiya; Hana Antonicka; Grant A Mitchell; Michael T Geraghty; Matthew Lines; Kym M Boycott; Eric A Shoubridge; John J Mitchell; Jacques L Michaud; Jacek Majewski
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

3.  Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency.

Authors:  Simone Olgiati; Matej Skorvanek; Marialuisa Quadri; Michelle Minneboo; Josja Graafland; Guido J Breedveld; Ramon Bonte; Zeliha Ozgur; Mirjam C G N van den Hout; Kees Schoonderwoerd; Frans W Verheijen; Wilfred F J van IJcken; Hsin Fen Chien; Egberto Reis Barbosa; Hsiu-Chen Chang; Szu-Chia Lai; Tu-Hsueh Yeh; Chin-Song Lu; Yah-Huei Wu-Chou; Anneke J A Kievit; Vladimir Han; Zuzana Gdovinova; Robert Jech; Robert M W Hofstra; George J G Ruijter; Wim Mandemakers; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2016-04-19       Impact factor: 10.338

4.  Paroxysmal dyskinesias: clinical features and classification.

Authors:  M Demirkiran; J Jankovic
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

5.  Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement.

Authors:  Tobias B Haack; Christopher B Jackson; Kei Murayama; Laura S Kremer; André Schaller; Urania Kotzaeridou; Maaike C de Vries; Gudrun Schottmann; Saikat Santra; Boriana Büchner; Thomas Wieland; Elisabeth Graf; Peter Freisinger; Sandra Eggimann; Akira Ohtake; Yasushi Okazaki; Masakazu Kohda; Yoshihito Kishita; Yoshimi Tokuzawa; Sascha Sauer; Yasin Memari; Anja Kolb-Kokocinski; Richard Durbin; Oswald Hasselmann; Kirsten Cremer; Beate Albrecht; Dagmar Wieczorek; Hartmut Engels; Dagmar Hahn; Alexander M Zink; Charlotte L Alston; Robert W Taylor; Richard J Rodenburg; Regina Trollmann; Wolfgang Sperl; Tim M Strom; Georg F Hoffmann; Johannes A Mayr; Thomas Meitinger; Ramona Bolognini; Markus Schuelke; Jean-Marc Nuoffer; Stefan Kölker; Holger Prokisch; Thomas Klopstock
Journal:  Ann Clin Transl Neurol       Date:  2015-03-13       Impact factor: 4.511

6.  Clinical and biochemical characterization of four patients with mutations in ECHS1.

Authors:  Sacha Ferdinandusse; Marisa W Friederich; Alberto Burlina; Jos P N Ruiter; Curtis R Coughlin; Megan K Dishop; Renata C Gallagher; Jirair K Bedoyan; Frédéric M Vaz; Hans R Waterham; Katherine Gowan; Kathryn Chatfield; Kaitlyn Bloom; Michael J Bennett; Orly Elpeleg; Johan L K Van Hove; Ronald J A Wanders
Journal:  Orphanet J Rare Dis       Date:  2015-06-18       Impact factor: 4.123

Review 7.  Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification.

Authors:  Roberto Erro; Una-Marie Sheerin; Kailash P Bhatia
Journal:  Mov Disord       Date:  2014-06-25       Impact factor: 10.338

  7 in total
  18 in total

1.  Mitochondrial Encephalopathy and Transient 3-Methylglutaconic Aciduria in ECHS1 Deficiency: Long-Term Follow-Up.

Authors:  Irene C Huffnagel; Egbert J W Redeker; Liesbeth Reneman; Frédéric M Vaz; Sacha Ferdinandusse; Bwee Tien Poll-The
Journal:  JIMD Rep       Date:  2017-07-29

Review 2.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

3.  An incidental finding in newborn screening leading to the diagnosis of a patient with ECHS1 mutations.

Authors:  S Pajares; R M López; L Gort; A Argudo-Ramírez; J L Marín; J M González de Aledo-Castillo; J García-Villoria; J A Arranz; M Del Toro; F Tort; O Ugarteburu; M D Casellas; R Fernández; A Ribes
Journal:  Mol Genet Metab Rep       Date:  2020-01-02

4.  Extrapolation of Variant Phase in Mitochondrial Short-Chain Enoyl-CoA Hydratase (ECHS1) Deficiency.

Authors:  Colleen M Carlston; Sacha Ferdinandusse; Judith A Hobert; Rong Mao; Nicola Longo
Journal:  JIMD Rep       Date:  2018-06-20

Review 5.  Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features.

Authors:  Serena Galosi; Francesca Nardecchia; Vincenzo Leuzzi
Journal:  Mov Disord Clin Pract       Date:  2020-02-04

Review 6.  Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm.

Authors:  Federica Rachele Danti; Federica Invernizzi; Isabella Moroni; Barbara Garavaglia; Nardo Nardocci; Giovanna Zorzi
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

7.  Exploring triheptanoin as treatment for short chain enoyl CoA hydratase deficiency.

Authors:  Kristin Engelstad; Rachel Salazar; Dorcas Koenigsberger; Erin Stackowtiz; Susan Brodlie; Melanie Brandabur; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-05-01       Impact factor: 4.511

8.  Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Authors:  Josua Kegele; Johanna Krüger; Mahmoud Koko; Lara Lange; Ana Victoria Marco Hernandez; Francisco Martinez; Alexander Münchau; Holger Lerche; Stephan Lauxmann
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

9.  Clinical, biochemical, and genetic features of four patients with short-chain enoyl-CoA hydratase (ECHS1) deficiency.

Authors:  Patricia E Fitzsimons; Charlotte L Alston; Penelope E Bonnen; Joanne Hughes; Ellen Crushell; Michael T Geraghty; Martine Tetreault; Peter O'Reilly; Eilish Twomey; Yusra Sheikh; Richard Walsh; Hans R Waterham; Sacha Ferdinandusse; Ronald J A Wanders; Robert W Taylor; James J Pitt; Philip D Mayne
Journal:  Am J Med Genet A       Date:  2018-03-25       Impact factor: 2.802

Review 10.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.